Pharmacology (Hons) Bangor University

Overview

At Bangor University will study how drugs are discovered and developed, how they are trialled in humans, and licensed for clinical use by regulatory agencies. Unique to this Pharmacology (Hons) degree delivered by Bangor University is the study of how medicines are approved by healthcare providers, such as the NICE (National Institute for Health and Care Excellence).

Key Facts

Learning is very much hands-on, grounded in the real-world experiences of lecturers and driven by the latest scientific research. Our own expertise includes, among other things, the use of computer modelling and simulation of drug dosing, exposure and action, investigation into the actions and toxicities of anticancer drugs, use of pharmacogenomics, and determination of the clinical benefit and cost-effectiveness of medicines.

We work closely with national and international organisations involved in pharmaceutical policy relating to pharmacogenomics, treatment of rare diseases and health service reimbursement. We offer a rich experience to develop skills that are relevant across the spectrum of pharmacology – from the basic sciences through to clinical use and policy, and which are transferable to maximise students’ employment potential.

If you study pharmacology at Bangor, you will be provided with opportunities to undertake projects exploring various cancer treatments, including cancer immunotherapy, clinical evaluation, toxicology, pharmacometrics and pharmacoeconomic evaluation.

*Courses validated by Bangor University are subject to review (approximately every 5 years) to ensure that the: course content remains relevant; curriculum reflects any changes prompted by developments in academic research; and that course quality continues to meet our high standards. When this process is undertaken the course will appear as being 'subject to revalidation'.